Limited effects of bile acids and small heterodimer partner on hepatitis B virus biosynthesis in vivo

Journal of Virology

Volumn 86, Issue 5, 2012, Pages 2760-2768

  Reese, Vanessa C ^a   Moore, David D ^b   McLachlan, Alan ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; CELL NUCLEUS RECEPTOR; COREPRESSOR PROTEIN; ESTROGEN RECEPTOR; FARNESOID X RECEPTOR; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; HETERODIMER; LIVER RECEPTOR HOMOLOG 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; RETINOID X RECEPTOR ALPHA; TRANSCRIPTION FACTOR; VIRUS DNA; VIRUS RNA;

ARTICLE; BIOSYNTHESIS; CONTROLLED STUDY; DIET; DNA SYNTHESIS; HEPATITIS B VIRUS; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RNA SYNTHESIS; TRANSGENIC MOUSE; VIREMIA; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

ANIMALS; BILE ACIDS AND SALTS; CELL LINE; DIMERIZATION; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; LIGANDS; LIVER; MALE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; PROTEIN BIOSYNTHESIS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; VIRUS REPLICATION;

HEPATITIS B VIRUS; MUS MUSCULUS;

EID: 84857806196     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.06742-11     Document Type: Article

References (64)

1. Ananthanarayanan M, Balasubramanian N, Makishima M, Mangelsdorf DJ, Suchy FJ. 2001. Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor. J. Biol. Chem. 276:28857-28865.
2. Anderson AL, Banks KE, Pontoglio M, Yaniv M, McLachlan A. 2005. Alpha/beta interferon differentially modulates the clearance of cytoplasmic encapsidated replication intermediates and nuclear covalently closed circular hepatitis B virus (HBV) DNA from the livers of hepatocyte nuclear factor 1 -null HBV transgenic mice. J. Virol. 79:11045-11052.
3. Banks KE, et al. 2002. Hepatocyte nuclear factor 3 inhibits hepatitis B virus replication in vivo. J. Virol. 76:12974-12980.
4. Bavner A, Sanyal S, Gustafsson JA, Treuter E. 2005. Transcriptional corepression by SHP: molecular mechanisms and physiological consequences. Trends Endocrinol. Metab. 16:478-488.
5. Chang C, et al. 1987. Production of hepatitis B virus in vitro by transient expression of cloned HBV DNA in a hepatoma cell line. EMBO J. 6:675-680.
6. Chen D, Lepar G, Kemper B. 1994. A transcriptional regulatory element common to a large family of hepatic cytochrome P450 genes is a functional binding site of the orphan receptor HNF-4. J. Biol. Chem. 269: 5420-5427.
7. Chiang JYL. 2009. Bile acids: regulation of synthesis. J. Lipid Res. 50: 1955-1966.
8. Chomczynski P, Sacchi N. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
9. Dubois MF, Pourcel C, Rousset S, Chany C, Tiollais P. 1980. Excretion of hepatitis B surface antigen particles from mouse cells transformed with cloned viral DNA. Proc. Natl. Acad. Sci. U. S. A. 77:4549-4553.
10. Galibert F, Mandart E, Fitoussi F, Tiollais P, Charnay P. 1979. Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli. Nature 281:646-650.
11. Gilbert S, Galarneau L, Lamontagne A, Roy S, Bélanger L. 2000. The hepatitis B virus core promoter is strongly activated by the liver nuclear receptor fetoprotein transcription factor or by ectopically expressed steroidogenic factor 1. J. Virol. 74:5032-5039.
12. Glebe D, Urban S. 2007. Viral and cellular determinants involved in hepadnaviral entry. World J. Gastroenterol. 13:22-38.
13. Goodwin B, et al. 2000. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol. Cell 6:517-526.
14. Guidotti LG, et al. 1999. In vivo regulation of hepatitis B virus replication by peroxisome proliferators. J. Virol. 73:10377-10386.
15. Guidotti LG, Matzke B, Schaller H, Chisari FV. 1995. High-level hepatitis B virus replication in transgenic mice. J. Virol. 69:6158-6169.
16. Huan B, Kosovsky MJ, Siddiqui A. 1995. Retinoid X receptor α transactivates the hepatitis B virus enhancer 1 element by forming a heterodimeric complex with the peroxisome proliferator-activated receptor. J. Virol. 69:547-551.
17. Huan B, Siddiqui A. 1992. Retinoid X receptor RXRα binds to and trans-activates the hepatitis B virus enhancer. Proc. Natl. Acad. Sci. U. S. A. 89:9059-9063.
18. Ishida H, et al. 2000. Identification of multiple transcription factors, HLF, FTF, and E4BP4, controlling hepatitis B virus enhancer II. J. Virol. 74: 1241-1251.
19. Kosovsky MJ, Qadri I, Siddiqui A. 1998. The regulation of hepatitis B virus gene expression: an overview of the cis- and trans-acting components, p 21-50. In Koshy R, Caselmann WH (ed), Hepatitis B virus: molecular mechanisms in disease and novel strategies for therapy. Imperial College Press, London, United Kingdom.
20. Kyrmizi I, et al. 2006. Plasticity and expanding complexity of the hepatic transcription factor network during liver development. Genes Dev. 20: 2293-2305.
21. Lavanchy D. 2004. Hepatitis B virus epidemiology, disease burden, treat- ment, and current and emerging prevention and control measures. J. Viral Hepat. 11:97-107.
22. Lee SST, et al. 1995. Targeted disruption of the isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol. Cell. Biol. 15: 3012-3022.
23. Li L, Oropeza CE, Kaestner KH, McLachlan A. 2009. Limited effects of fasting on hepatitis B virus (HBV) biosynthesis in HBV transgenic mice. J. Virol. 83:1682-1688.
24. Li L, et al. 2009. Developmental regulation of hepatitis B virus biosynthesis by hepatocyte nuclear factor 4α. PLoS One 4:e5489.
25. Li M, et al. 1998. Cloning and characterization of a novel human hepatocyte transcription factor, hB1F, which binds and activates enhancer II of hepatitis B virus. J. Biol. Chem. 273:29022-29031.
26. -ΔΔCt method. Methods 25: 402-408.
27. Lok AS, Heathcote EJ, Hoofnagle JH. 2001. Management of hepatitis B: 2000-summary of a workshop. Gastroenterology 120:1828-1853.
28. Lu TT, et al. 2000. Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol. Cell 6:507-515.
29. Ma K, Saha PK, Chan L, Moore DD. 2006. Farnesoid X receptor is essential for normal glucose homeostasis. J. Clin. Invest. 116:1102-1109.
30. Makishima M, et al. 1999. Identification of a nuclear receptor for bile acids. Science 284:1362-1365.
31. Mangelsdorf DJ, Ong ES, Dyck JA, Evans RM. 1990. Nuclear receptor that identifies a novel retinoic acid response pathway. Nature 345:224-229.
32. McLachlan A, et al. 1987. Expression of hepatitis B virus surface and core antigens: influences of pre-S and precore sequences. J. Virol. 61:683-692.
33. Moschetta A, Bookout AL, Mangelsdorf DJ. 2004. Prevention of cholesterol gallstone disease by FXR agonists in a mouse model. Nat. Med. 10: 1352-1358.
34. Ondracek CR, McLachlan A. 2011. Role of peroxisome proliferatoractivated receptor gamma coactivator 1 in AKT/PKB-mediated inhibition of hepatitis B virus biosynthesis. J. Virol. 85:11891-11900.
35. Ondracek CR, Reese VC, Rushing CN, Oropeza CE, McLachlan A. 2009. Distinct regulation of hepatitis B virus biosynthesis by peroxisome proliferator-activated receptor γ coactivator 1α and small heterodimer partner in human hepatoma cell lines. J. Virol. 83:12545-12551.
36. Ondracek CR, Rushing CN, Reese VC, Oropeza CE, McLachlan A. 2009. Peroxisome proliferator-activated receptor γ coactivator 1α and small heterodimer partner differentially regulate nuclear receptordependent hepatitis B virus biosynthesis. J. Virol. 83:12535-12544.
37. Oropeza CE, Li L, McLachlan A. 2008. Differential inhibition of nuclear hormone receptor dependent hepatitis B virus replication by small heterodimer partner. J. Virol. 82:3814-3821.
38. Overbergh L, Valckx D, Waer M, Mathieu C. 1999. Quantification of murine cytokine mRNAs using real time quantitative reverse transcriptase PCR. Cytokine 11:305-312.
39. Parks DJ, et al. 1999. Bile acids: natural ligands for an orphan nuclear receptor. Science 284:1365-1368.
40. Ramiere C, et al. 2008. Transactivation of the hepatitis B virus core promoter by the nuclear receptor FXRα. J. Virol. 82:10832-10840.
41. Raney AK, et al. 2001. Nuclear covalently closed circular viral genomic DNA in the liver of hepatocyte nuclear factor 1α -null hepatitis B virus transgenic mice. J. Virol. 75:2900-2911.
42. Raney AK, Johnson JL, Palmer CNA, McLachlan A. 1997. Members of the nuclear receptor superfamily regulate transcription from the hepatitis B virus nucleocapsid promoter. J. Virol. 71:1058-1071.
43. Raney AK, Kline EF, Tang H, McLachlan A. 2001. Transcription and replication of a natural hepatitis B virus nucleocapsid promoter variant is regulated in vivo by peroxisome proliferators. Virology 289:239-251.
44. Reese VC, et al. 2011. Multiple nuclear receptors may regulate hepatitis B virus biosynthesis during development. Int. J. Biochem. Cell Biol. 43:230-237.
45. Sabath DE, Broome HE, Prystowsky MB. 1990. Glyceraldehyde-3- phosphate dehydrogenase mRNA is a major interleukin 2-induced transcript in a cloned T-helper lymphocyte. Gene 91:185-191.
46. Sambrook J, Fritsch EF, Maniatis T. 1989.Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
47. Schaller H, Fischer M. 1991. Transcriptional control of hepadnavirus gene expression. Curr. Top. Microbiol. Immunol. 168:21-39.
48. Sells MA, Chen M-L, Acs G. 1987. Production of hepatitis B virus particles in HepG2 cells transfected with cloned hepatitis B virus DNA. Proc. Natl. Acad. Sci. U. S. A. 84:1005-1009.
49. Seol W, Choi HS, Moore DD. 1996. An orphan nuclear hormone receptor that lacks a DNA binding domain and heterodimerizes with other receptors. Science 272:1336-1339.
50. Summers J, Smith PM, Huang M, Yu M. 1991. Morphogenetic and regulatory effects of mutations in the envelope proteins of an avian hepadnavirus. J. Virol. 65:1310-1317.
51. Sureau C, Romet-Lemonne J-L, Mullins JI, Essex M. 1986. Production of hepatitis B virus by a differentiated human hepatoma cell line after transfection with cloned circular HBV DNA. Cell 47:37-47.
52. Tang H, Banks KE, Anderson AL, McLachlan A. 2001. Hepatitis B virus transcription and replication. Drug News Perspect. 14:325-334.
53. Tang H, McLachlan A. 2001. Transcriptional regulation of hepatitis B virus by nuclear hormone receptors is a critical determinant of viral tropism. Proc. Natl. Acad. Sci. U. S. A. 98:1841-1846.
54. Tsurimoto T, Fujiyama A, Matsubara K. 1987. Stable expression and replication of hepatitis B virus genome in an integrated state in a human hepatoma cell line transfected with the cloned viral DNA. Proc. Natl. Acad. Sci. U. S. A. 84:444-448.
55. Wang L, Han Y, Kim CS, Lee YK, Moore DD. 2003. Resistance of SHP-null mice to bile acid-induced liver damage. J. Biol. Chem. 278: 44475-44481.
56. Wang L, et al. 2002. Redundant pathways for negative feedback regulation of bile acid production. Dev. Cell 2:721-731.
57. Weimer T, Salfeld J, Will H. 1987. Expression of the hepatitis B virus core gene in vitro and in vivo. J. Virol. 61:3109-3113.
58. Will H, et al. 1987. Replication strategy of human hepatitis B virus. J. Virol. 61:904-911.
59. Yaginuma K, Shirakata Y, Kobayashi M, Koike K. 1987. Hepatitis B virus (HBV) particles are produced in a cell culture system by transient expression of transfected HBV DNA. Proc. Natl. Acad. Sci. U. S. A. 84: 2678-2682.
60. Yan Z, et al. 2011. A cis-acting regulatory variation of the estrogen receptor (ESR1) gene is associated with hepatitis B virus-related liver cirrhosis. Hum. Mutat. 32:1128-1136.
61. Yen TSB. 1993. Regulation of hepatitis B virus gene expression. Semin. Virol. 4:33-42.
62. Yu XM, Mertz JE. 1997. Differential regulation of the pre-C and pregenomic promoters of human hepatitis B virus by members of the nuclear receptor superfamily. J. Virol. 71:9366-9374.
63. Yu XM, Mertz JE. 2001. Critical roles of nuclear receptor response elements in replication of hepatitis B virus. J. Virol. 75:11354-11364.
64. Zheng YY, Li J, Ou JH. 2004. Regulation of hepatitis B virus core promoter by transcription factors HNF1 and HNF4 and the viral X protein. J. Virol. 78:6908-6914.